Home > News > Nanogen to Acquire Amplimedical
April 20th, 2006
Nanogen to Acquire Amplimedical
Abstract:
Nanogen, Inc. (Nasdaq: NGEN), developer and manufacturer of advanced diagnostic products, and Amplimedical S.p.A., a manufacturer of molecular diagnostic products and a wholly owned subsidiary of Amplifon (La Borsa: AMP), today announced that Nanogen will acquire the assets of Amplimedical's diagnostics division in a transaction of 8.1 million Euros consisting of 2.0 million Euros in cash and 6.1 million Euros in a promissory note convertible into Nanogen common shares.
Source:
prnewswire
Bookmark:
Investments/IPO's/Splits
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
Iran to Hold Int'l Forum on Nanotechnology Economy (IFNE2013) May 30th, 2013
Nanomedicine
European Technology Platform for Nanomedicine and Nanomed2020 European Consortium Launch the Nanomedicine Award June 17th, 2013
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Iranian Scientists Produce Dynamometer for Nanoparticles, Biocells June 15th, 2013
Discovery of new material state counterintuitive to laws of physics June 14th, 2013
Announcements
An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013
Polymer-coated catalyst protects "artificial leaf" June 17th, 2013
Efficient and inexpensive: Researchers develop catalyst material for fuel cells: Platinum-nickel nano-octahedra save 90 percent platinum June 17th, 2013
AXEON Acquires Assets of Leading Reverse Osmosis Systems Manufacturer June 17th, 2013